ArticleDrugs - real world outcomes2022

Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib.

Emily Nash Smyth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.